The Business of Medical-Grade TPEs: Opportunities for Polymer Manufacturers and Compounders

Overview

Medical devices increasingly require materials that combine flexibility, durability, chemical resistance and reliable performance. Thermoplastic elastomers (TPEs) are gaining attention in this space because they combine rubber-like elasticity with the processing advantages of thermoplastics.

Medical-grade TPEs are used in applications such as medical tubing, flexible connectors, seals, grips, drug delivery components and wearable healthcare devices. Their ability to be processed through injection moulding, extrusion and other conventional polymer manufacturing techniques makes them relevant to medical device manufacturers seeking specialised material solutions.

For polymer producers and compounders, this creates opportunities beyond supplying standard resin. Businesses can develop application-specific formulations, manufacture customised compounds and support medical device companies with material selection, processing guidance and quality documentation.

However, medical applications require more than flexibility or mechanical performance. Material consistency, chemical composition, biological safety, sterilisation compatibility and manufacturing controls all influence whether a TPE formulation is suitable for a particular medical device.

Understanding Medical-Grade Thermoplastic Elastomers

Thermoplastic elastomers are polymer materials that exhibit elastic behaviour while retaining the ability to be processed using thermoplastic manufacturing methods. Unlike conventional vulcanised rubber, many TPE formulations can be softened through heating and reshaped during processing.

This combination makes TPEs useful for medical products that need flexibility, soft-touch surfaces, repeated deformation or precise moulded geometries.

The global medical-grade thermoplastic elastomer (TPE) compounds market size was estimated at USD 1.37 billion in 2025 and is predicted to increase from USD 1.5 billion in 2026 to approximately USD 3.41 billion by 2035, expanding at a CAGR of 9.55% from 2026 to 2035

Several TPE families are relevant to medical applications:

• Styrenic block copolymers (TPE-S): Often used in soft-touch components, flexible grips, seals and tubing formulations.
• Thermoplastic polyurethanes (TPU): Offer a combination of flexibility, abrasion resistance and mechanical strength, making them useful in selected tubing, catheter and device applications.
• Thermoplastic polyolefins (TPO): Can provide flexible, lightweight material options for selected housings and components.
• Thermoplastic vulcanizates (TPV): Combine an elastomeric phase with a thermoplastic matrix and can offer useful compression-set and flexibility characteristics.
• Thermoplastic copolyesters (TPC): Provide a balance of elasticity, mechanical strength and chemical resistance for selected engineered components.

Not every TPE family is suitable for every medical application. The appropriate material depends on the intended use, contact with the human body, exposure conditions, sterilisation method and required product performance.

Where Are Medical-Grade TPEs Used?

The commercial opportunity for TPE suppliers comes from the wide range of medical components that require controlled flexibility, sealing, cushioning or fluid handling.

1. Medical Tubing and Fluid Management

Medical tubing is used in infusion systems, drainage products, respiratory equipment and other fluid management applications. These products require consistent dimensions, flexibility and resistance to kinking or deformation.

Selected TPE formulations can be developed for tubing that needs to bend during use while maintaining its internal flow path. Material selection must also consider fluid compatibility, extractables, flexibility and the intended duration of contact.

For compounders, this creates opportunities to develop formulations with specific hardness, extrusion behaviour and chemical resistance.

2. Catheters and Minimally Invasive Devices

Catheters and other minimally invasive devices require materials that support controlled flexibility, pushability and patient comfort. Different sections of a device may require different mechanical properties.

TPU and selected TPE formulations can be considered for catheter components, flexible shafts, connectors and other specialised parts. However, the material must be evaluated for its intended contact with tissue, blood or other body fluids.

Manufacturers may require customised grades that balance flexibility, tensile strength, surface characteristics and dimensional stability.

3. Drug Delivery Systems

Drug delivery devices use several polymer components, including seals, flexible interfaces, connectors and soft-touch parts.

TPEs can be considered for selected components in injection devices, wearable drug delivery systems and other medication administration products. Their suitability depends on compatibility with the drug formulation, contact duration, mechanical requirements and manufacturing process.

This segment offers opportunities for compounders that can provide controlled formulations and consistent material properties for precision-moulded components.

4. Wearable Medical Devices

Wearable healthcare products require materials that remain comfortable during extended use. Flexible housings, straps, seals and skin-contacting interfaces may use elastomeric materials.

Medical-grade TPEs can support soft-touch surfaces and flexible product designs. For skin-contact applications, manufacturers must consider irritation, sensitisation, chemical constituents and the actual duration of contact.

As wearable medical devices become more specialised, suppliers that can develop application-specific softness, durability and surface properties may gain opportunities with device manufacturers.

5. Medical Connectors, Seals and Components

Connectors, valves, gaskets and sealing components play an important role in medical fluid delivery and equipment performance.

TPEs can provide flexibility and sealing characteristics in selected applications. Manufacturers must assess compression behaviour, dimensional consistency, chemical resistance and compatibility with the mating components.

These products also create opportunities for precision moulders and compounders that can work together on customised component designs.

The Medical TPE Manufacturing Value Chain

The commercial ecosystem extends beyond polymer production. Different businesses participate in material development, compounding, component manufacturing, testing and final device assembly.

This structure creates opportunities for businesses at different stages of the supply chain. A polymer producer may focus on resin development, while a compounder can differentiate itself through formulation expertise and technical support.

Component manufacturers can also create value by combining material knowledge with precision extrusion, injection moulding and product validation.

Why Medical-Grade TPE Compounding Is a Commercial Opportunity

Compounding is an important part of the medical TPE supply chain. It involves combining a base polymer with selected additives, modifiers, colourants or other ingredients to achieve specific performance requirements.

Medical device manufacturers may not always need a standard commercial polymer grade. Their products often require a material with a defined combination of hardness, flexibility, tensile strength, flow characteristics and chemical compatibility.

This creates demand for specialised compounding capabilities.

Application-Specific Formulations

A tubing manufacturer may prioritise flexibility and extrusion stability, while a connector producer may require sealing performance and dimensional accuracy.

Compounders can develop formulations around these requirements rather than supplying one general-purpose material for every application.

Custom Hardness and Mechanical Performance

TPE hardness is commonly specified using Shore hardness scales. Compounders can adjust formulations to achieve different levels of softness and stiffness.

Other important parameters include tensile strength, elongation at break, tear resistance, compression set and recovery after deformation.

The challenge is to achieve the required mechanical properties without compromising other material characteristics.

Colour and Product Identification

Medical components may require specific colours for product identification, visual inspection or design purposes.

Compounders can develop controlled colour formulations, but pigments and colour additives must be assessed for compatibility with the intended medical application. Changes in additives may also affect biological and chemical evaluations.

Processing and Manufacturing Support

Medical component manufacturers need materials that perform consistently during extrusion, injection moulding or other production processes.

Compounders that provide technical assistance, processing recommendations and batch-level documentation can develop stronger relationships with medical device customers.

What Do Medical Device Manufacturers Expect From TPE Suppliers?

Medical device companies evaluate materials based on more than price and physical performance. Suppliers must demonstrate that their materials can meet the technical and quality requirements of the intended application.

Important purchasing considerations include:

1. Material consistency: Consistent hardness, colour, tensile properties and processing behaviour across production batches.

2. Chemical composition: Clear information about polymers, additives, processing aids and other relevant constituents.

3. Biocompatibility information: Supporting data that helps the device manufacturer assess biological risks for the intended application.

4. Sterilisation compatibility: Evidence that the material can maintain required properties after the sterilisation method used for the finished product.

5. Traceability: Lot identification, material specifications, change notifications and documentation supporting quality investigations.

6. Technical support: Assistance with material selection, moulding, extrusion, troubleshooting and product development.

Suppliers that can combine these capabilities may become more valuable development partners rather than remaining interchangeable resin vendors.

Testing and Regulatory Requirements

Medical-grade TPE development requires careful attention to biological safety and product performance. A material described as medical grade is not automatically approved for every medical device.

The U.S. Food and Drug Administration's September 2023 guidance on ISO 10993-1 explains how biological evaluation should be approached through a risk management process. The evaluation considers the nature and duration of body contact and the potential biological risks associated with the finished device.

The FDA also clarifies that biocompatibility is assessed for the final finished medical device, not simply by accepting a supplier's material description.

Important evaluation areas include:

• Biological evaluation: Assessment of relevant endpoints such as cytotoxicity, irritation and sensitisation, depending on the intended use and risk assessment.
• Chemical characterisation: Examination of material constituents and potentially released substances.
• Mechanical testing: Evaluation of tensile strength, elongation, tear resistance, hardness and compression behaviour.
• Chemical resistance: Assessment of compatibility with relevant fluids, cleaning agents and drug formulations.
• Sterilisation validation: Verification that the material maintains required performance after the applicable sterilisation process.
• Dimensional stability: Assessment of changes in dimensions and physical properties during processing and use.

ISO 10993-1 provides a framework for biological evaluation, while ISO 14971 supports medical device risk management. Other applicable standards and test methods depend on the product category.

For TPE suppliers, the practical implication is clear: material documentation and formulation control should be established early in product development. A change in resin supplier, additive package or manufacturing process may require reassessment of the biological and technical evidence.

Sterilisation Compatibility: An Important Material Selection Factor

Medical devices may undergo sterilisation using ethylene oxide (EtO), gamma radiation, electron beam or steam, depending on the product and its design.

TPE formulations can respond differently to these processes. Exposure may affect colour, hardness, elasticity, tensile strength or other material properties.

For example, radiation exposure may cause changes in polymer structure, while heat and moisture can affect materials that are not designed for steam sterilisation.

Compounders should therefore work with device manufacturers to understand the intended sterilisation process before finalising a formulation.

Repeated sterilisation exposure also needs consideration for reusable devices. Testing should reflect the actual product configuration and the number of cycles expected during use.

Manufacturing Investment and Infrastructure Requirements

Entering the medical TPE supply chain requires more than installing standard polymer processing equipment. Manufacturers need systems that support material consistency, contamination control and documented quality management.

Key investment areas include:

Compounding equipment: Suitable twin-screw extruders, controlled feeding systems, mixing equipment and pelletising lines.

Quality control laboratories: Equipment for hardness, tensile strength, elongation, melt flow and other relevant physical properties.

Process monitoring: Controls for temperature, pressure, mixing conditions and production parameters.

Clean manufacturing practices: Appropriate housekeeping, material handling and contamination prevention based on the product's requirements.

Documentation systems: Batch records, raw material traceability, formulation controls and change management.

Technical expertise: Polymer scientists, process engineers, quality specialists and regulatory professionals.

Businesses entering this segment should also assess whether their existing production facilities can meet customer-specific quality requirements or whether dedicated production areas and additional controls are necessary.

Key Business Opportunities for Polymer Manufacturers and Compounders

The medical TPE supply chain offers several commercial entry points.

1. Developing Specialised Medical TPE Grades

Polymer producers and compounders can invest in formulations for tubing, connectors, seals, wearable devices and drug delivery components.

The commercial advantage comes from solving a specific material requirement rather than competing only on general-purpose resin pricing.

2. Contract Compounding for Medical Device Companies

Some medical device manufacturers may prefer to work with external compounders rather than develop every formulation internally.

Contract compounding can provide a route into the medical supply chain, particularly when suppliers offer formulation control, traceability and technical support.

3. Localising Material Supply

Medical device manufacturers may seek additional qualified material suppliers to improve supply continuity and reduce dependence on a limited supplier base.

Local polymer producers and compounders can explore opportunities through technical collaboration, customer qualification and application-specific product development.

However, local availability alone is not sufficient. Suppliers must demonstrate consistent quality and meet the customer's validation requirements.

4. Supplying Precision-Moulded Components

Businesses with injection moulding and extrusion capabilities can move further along the value chain by producing finished or semi-finished components.

Potential products include seals, flexible connectors, tubing, device grips and specialised interfaces.

This approach can offer stronger customer integration than supplying raw polymer alone.

5. Building Testing and Technical Support Capabilities

Material suppliers can strengthen their commercial proposition through in-house testing, application development and technical assistance.

Access to reliable testing facilities also helps identify formulation or processing problems before commercial production.

Challenges That Can Affect Market Entry

Despite the opportunities, medical-grade TPE manufacturing involves several barriers.

High qualification requirements: Medical device manufacturers may conduct extensive supplier assessments and material validation before approving a new formulation.

Development costs: Formulation development, testing, equipment upgrades and quality systems require investment.

Long customer approval cycles: Material changes can affect finished-device performance and biological safety, making customers cautious about introducing new suppliers.

Raw material dependency: Specialised polymer grades and additives may depend on a limited number of suppliers, creating procurement and supply continuity risks.

Regulatory complexity: Requirements differ according to the device, intended use and target market. Suppliers must understand the documentation expected by their customers.

Formulation change control: Even small changes to additives, pigments, processing aids or resin sources can affect material performance and require reassessment.

For new entrants, focusing on a specific application and building technical relationships with device manufacturers may be more practical than attempting to serve every medical TPE segment at once.

What Should Investors and Manufacturers Evaluate?

Businesses considering investment in medical TPE production or compounding should examine the commercial and technical potential of each application.

Important evaluation areas include:

• Customer demand: Which medical device categories require flexible polymer components?
• Application requirements: What hardness, elasticity, chemical resistance and sterilisation compatibility are needed?
• Supplier competition: Which polymer producers and compounders already supply qualified materials?
• Manufacturing capability: Can the company produce consistent formulations at the required scale?
• Qualification requirements: What testing, documentation and customer validation are necessary?
• Supply chain exposure: Are base polymers and additives available from reliable sources?
• Commercial viability: Can the company secure repeat orders and maintain acceptable production margins?

A focused assessment of these factors can help manufacturers identify where investment in medical TPE capabilities is commercially justified.

References

Medical-Grade Thermoplastic Elastomers (TPE) Compounds Market

Medical Polymers Market